88 related articles for article (PubMed ID: 22488775)
1. Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells.
Xie C; Edwards H; Lograsso SB; Buck SA; Matherly LH; Taub JW; Ge Y
Pediatr Blood Cancer; 2012 Dec; 59(7):1245-51. PubMed ID: 22488775
[TBL] [Abstract][Full Text] [Related]
2. The role of clofarabine in acute myeloid leukemia.
Ghanem H; Kantarjian H; Ohanian M; Jabbour E
Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
[TBL] [Abstract][Full Text] [Related]
3. The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling.
Valdez BC; Li Y; Murray D; Champlin RE; Andersson BS
Biochem Pharmacol; 2011 Jan; 81(2):222-32. PubMed ID: 20933509
[TBL] [Abstract][Full Text] [Related]
4. Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro.
Chen WA; Williams TG; So L; Drew N; Fang J; Ochoa P; Nguyen N; Jawhar Y; Otiji J; Duerksen-Hughes PJ; Reeves ME; Casiano CA; Jin H; Dovat S; Yang J; Boyle KE; Francis-Boyle OL
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673926
[TBL] [Abstract][Full Text] [Related]
5. Use of clofarabine for acute childhood leukemia.
Pession A; Masetti R; Kleinschmidt K; Martoni A
Biologics; 2010 Jun; 4():111-8. PubMed ID: 20631817
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents.
Fredly H; Gjertsen BT; Bruserud O
Clin Epigenetics; 2013 Jul; 5(1):12. PubMed ID: 23898968
[TBL] [Abstract][Full Text] [Related]
7. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.
Mussai F; Egan S; Higginbotham-Jones J; Perry T; Beggs A; Odintsova E; Loke J; Pratt G; U KP; Lo A; Ng M; Kearns P; Cheng P; De Santo C
Blood; 2015 Apr; 125(15):2386-96. PubMed ID: 25710880
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of adavosertib and fimepinostat on acute myeloid leukemia cells by enhancing the induction of DNA damage.
Wang Y; Lin X; Wang Y; Wang G
Invest New Drugs; 2024 Feb; 42(1):70-79. PubMed ID: 38085423
[TBL] [Abstract][Full Text] [Related]
9. Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study.
Swords RT; Azzam D; Al-Ali H; Lohse I; Volmar CH; Watts JM; Perez A; Rodriguez A; Vargas F; Elias R; Vega F; Zelent A; Brothers SP; Abbasi T; Trent J; Rangwala S; Deutsch Y; Conneally E; Drusbosky L; Cogle CR; Wahlestedt C
Leuk Res; 2018 Jan; 64():34-41. PubMed ID: 29175379
[TBL] [Abstract][Full Text] [Related]
10. Clofarabine and Cytarabine Regimen for Acute Myeloid Leukemia.
Ho KV; Solimando DA; Waddell JA
Hosp Pharm; 2015 Nov; 50(11):969-74. PubMed ID: 27621503
[TBL] [Abstract][Full Text] [Related]
11. c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia.
Liu S; Qiao X; Wu S; Gai Y; Su Y; Edwards H; Wang Y; Lin H; Taub JW; Wang G; Ge Y
Apoptosis; 2022 Dec; 27(11-12):913-928. PubMed ID: 35943677
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation.
Bruserud Ø; Tsykunova G; Hernandez-Valladares M; Reikvam H; Tvedt THA
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34063204
[TBL] [Abstract][Full Text] [Related]
13. HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia.
Spreafico M; Gruszka AM; Valli D; Mazzola M; Deflorian G; Quintè A; Totaro MG; Battaglia C; Alcalay M; Marozzi A; Pistocchi A
Front Cell Dev Biol; 2020; 8():844. PubMed ID: 33015043
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia.
Ma J; Zhao S; Qiao X; Knight T; Edwards H; Polin L; Kushner J; Dzinic SH; White K; Wang G; Zhao L; Lin H; Wang Y; Taub JW; Ge Y
Clin Cancer Res; 2019 Nov; 25(22):6815-6826. PubMed ID: 31320594
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocyte lineage development is controlled by modulation of protein acetylation.
Bartels M; Govers A; Polak R; Vervoort S; van Boxtel R; Pals C; Bierings M; van Solinge W; Egberts T; Nieuwenhuis E; Mokry M; Coffer PJ
PLoS One; 2018; 13(4):e0196400. PubMed ID: 29698469
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.
Luedtke DA; Niu X; Pan Y; Zhao J; Liu S; Edwards H; Chen K; Lin H; Taub JW; Ge Y
Signal Transduct Target Ther; 2017; 2():17012. PubMed ID: 29263915
[TBL] [Abstract][Full Text] [Related]
17. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells.
Saha SK; Yin Y; Kim K; Yang GM; Dayem AA; Choi HY; Cho SG
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498322
[TBL] [Abstract][Full Text] [Related]
18. Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells.
Niu X; Zhao J; Ma J; Xie C; Edwards H; Wang G; Caldwell JT; Xiang S; Zhang X; Chu R; Wang ZJ; Lin H; Taub JW; Ge Y
Clin Cancer Res; 2016 Sep; 22(17):4440-51. PubMed ID: 27103402
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer.
Wang G; Niu X; Zhang W; Caldwell JT; Edwards H; Chen W; Taub JW; Zhao L; Ge Y
Cancer Lett; 2015 Jan; 356(2 Pt B):656-68. PubMed ID: 25458954
[TBL] [Abstract][Full Text] [Related]
20. Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage.
Xie C; Edwards H; Caldwell JT; Wang G; Taub JW; Ge Y
Mol Oncol; 2015 Feb; 9(2):409-21. PubMed ID: 25308513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
